S100A8 is highly expressed in the cytosol of some immune cells including neutrophils, macrophages, and dendritic cells, and is induced by toll-like receptor (TLR) agonists, and S100A9 inhibits myeloid differentiation thereby contributing to tumor growth. Here, S100A9 is linked to neoplasm.